Use of mizoribine as a rescue drug for steroid-resistant pediatric IgA nephropathy

Pediatric Nephrology

Volumn 23, Issue 4, 2008, Pages 645-650

  Ikezumi, Yohei ^a   Suzuki, Toshiaki ^a   Karasawa, Tamaki ^a   Kawachi, Hiroshi ^b   Nikolic Paterson, David J ^c,d   Uchiyama, Makoto ^a  

^a NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c MONASH MEDICAL CENTRE   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

14 3 3 protein; Activated macrophage; Childhood; Heat shock protein (HSP) 60; IgA nephropathy; Mizoribine

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; HEAT SHOCK PROTEIN 60; METHYLPREDNISOLONE; MIZORIBINE; PREDNISOLONE; STEROID; WARFARIN;

ADOLESCENT; ARTICLE; CASE REPORT; CELL PROLIFERATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEMATURIA; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MACROPHAGE ACTIVATION; MESANGIUM CELL; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD;

ADOLESCENT; CHILD; DRUG RESISTANCE; FEMALE; GLOMERULONEPHRITIS, IGA; HEMATURIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MACROPHAGE ACTIVATION; METHYLPREDNISOLONE; PREDNISOLONE; PROTEINURIA; RIBONUCLEOSIDES; TREATMENT OUTCOME;

EID: 40549102494     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0664-2     Document Type: Article

References (16)

1. Kusumoto Y, Takebayashi S, Taguchi T, Harada T, Naito S (1987) Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and adult Japanese. Clin Nephrol 28:118-124
2. Wyatt RJ, Kritchevsky SB, Woodford SY, Miller PM, Roy S 3rd, Holland NH, Jackson E, Bishof NA (1995) IgA nephropathy: Long-term prognosis for pediatric patients. J Pediatr 127:913-919
3. Yoshikawa N, Ito H, Nakamura H (1988-1989) IgA nephropathy in children from Japan Clinical and pathological features. Child Nephrol Urol 9:191-199
4. Nagaoka R, Kaneko K, Ohtomo Y, Yamashiro Y (2002) Mizoribine treatment for childhood IgA nephropathy. Pediatr Int 44:217-223
5. Kawasaki Y, Suzuki J, Sakai N, Etoh S, Murai H, Nozawa R, Suzuki H (2004) Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy. Am J Nephrol 24:147-153
6. Kawasaki Y, Hosoya M, Suzuki J, Onishi N, Takahashi A, Isome M, Nozawa R, Suzuki H (2004) Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy. Am J Nephrol 24:576-581
7. Ikezumi Y, Suzuki T, Hayafuji S, Okubo S, Nikolic-Paterson DJ, Kawachi H, Shimizu F, Uchiyama M (2005) The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis. Nephrol Dial Transplant 20:2704-2713
8. Ikezumi Y, Suzuki T, Imai N, Ueno M, Narita I, Kawachi H, Shimizu F, Nikolic-Paterson DJ, Uchiyama M (2006) Histological differences in new-onset IgA nephropathy between children and adults. Nephrol Dial Transplant 21:3466-3474
9. Hamasaki T, Mori M, Kinoshita Y, Saeki T, Sakano T (1997) Mizoribine in steroid-dependent nephrotic syndrome of childhood. Pediatr Nephrol 11:625-627
10. Hughes SE, Gruber SA (1996) New immunosuppressive drugs in organ transplantation. J Clin Pharmacol 36:1081-1092
11. Sato N, Shiraiwa K, Kai K, Watanabe A, Ogawa S, Kobayashi Y, Yamagishi-Imai H, Utsunomiya Y, Mitarai T (2001) Mizoribine ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. Nephron 89:177-185
12. Kikuchi Y, Imakiire T, Yamada M, Saigusa T, Hyodo T, Hyodo N, Suzuki S, Miura S (2005) Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats. Nephrol Dial Transplant 20:1573-1581
13. Zhong B, Tajima M, Takahara H, Nochi H, Tamoto K, Tamura N, Kobayashi S, Tamura Y, Ikeda M, Akimoto T, Yoshino S, Hashimoto H (2005) Inhibitory effect of mizoribine on matrix metalloproteinase-1 production in synovial fibroblasts and THP-1 macrophages. Mod Rheumatol 15:264-268
14. Takahashi S, Wakui H, Gustafsson JA, Zilliacus J, Itoh H (2000) Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein. Biochem Biophys Res Commun 274:87-92
15. Itoh H, Komatsuda A, Wakui H, Miura AB, Tashima Y (1999) Mammalian HSP60 is a major target for an immunosuppressant mizoribine. J Biol Chem 274:35147-35151
16. Lang A, Benke D, Eitner F, Engel D, Ehrlich S, Breloer M, Hamilton-Williams E, Specht S, Hoerauf A, Floege J, von Bonin A, Kurts C (2005) Heat shock protein 60 is released in immune-mediated glomerulonephritis and aggravates disease: In vivo evidence for an immunologic danger signal. J Am Soc Nephrol 16:383-931